Skip to main content

Table 4 Univariate and multivariate Cox proportional hazard regression analysis for DM patients

From: Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study

Clinical outcomes (n, %)

Univariate multivariate

HR (95% CI)

P

HR (95% CI)

P

MACE

1.245 (0.935–1.656)

0.133

1.252 (0.939–1.669)

0.126

 All-cause death

0.986 (0.407–2.389)

0.976

0.953 (0.387–2.351)

0.917

 Cardiac death

0.555 (0.128–2.412)

0.432

0.410 (0.089–1.879)

0.251

 Non-fatal MI

1.808 (0.992–3.295)

0.053

1.689 (0.913–3.122)

0.095

 Stent thrombosis

1.116 (0.419–2.974)

0.826

1.002 (0.370–2.714)

0.997

 Revascularization

1.205 (0.846–1.717)

0.300

1.215 (0.852–1.733)

0.283

  TVR

1.329 (0.843–2.096)

0.221

1.325 (0.835–2.101)

0.232

  TLR

1.495 (0.923–2.422)

0.103

1.453 (0.891–2.371)

0.134

 Stroke

0.681 (0.237–1.950)

0.474

0.731 (0.253–2.111)

0.563

Bleeding

0.748 (0.471–1.188)

0.219

0.727 (0.447–1.182)

0.198

 BRAC 2_5

0.710 (0.337–1.497)

0.368

0.705 (0.333–1.491)

0.360

 BRAC 3_5

0.554 (0.069–4.432)

0.578

0.563 (0.070–4.535)

0.590

  1. DM diabetes mellitus, G2-DES second generation drug-eluting stent, BP-DES biodegradable polymer drug-eluting stent, MACE major adverse cardiac events, MI myocardial infarction, TVR target vessel revascularization, BARC Bleeding Academic Research Consortium definition